FIGURE 2.
Growth inhibitory effects of TGF-β1 and TGF-β2 on CCL-185 cells. CCL-185 cells were exposed to recombinant human TGF-β1 and TGF-β2 in concentrations ranging from 0 to 10 ng/mL, and cell viability was assessed by the WST-1 assay.
Growth inhibitory effects of TGF-β1 and TGF-β2 on CCL-185 cells. CCL-185 cells were exposed to recombinant human TGF-β1 and TGF-β2 in concentrations ranging from 0 to 10 ng/mL, and cell viability was assessed by the WST-1 assay.